Syed A Ahmad
Overview
Explore the profile of Syed A Ahmad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
195
Citations
3197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu O, Sun P, Ahmad S, Kalra A, Feng A, Whitman G, et al.
Perfusion
. 2025 Mar;
:2676591251319684.
PMID: 40025739
Purpose: Sparse data exist on delirium in VA-ECMO. We aim to describe the characteristics, risk factors, and outcomes of delirium in VA-ECMO. Methods: We retrospectively reviewed adults's electronic medical records...
2.
Patel S, Colby S, Sohal D, Guthrie K, Kachnic L, Chiorean E, et al.
Cancer
. 2025 Feb;
131(4):e35759.
PMID: 39932777
Background: Chemotherapy is required to improve the overall survival (OS) of patients with resectable pancreatic ductal adenocarcinoma (PDAC). Assessing the impact of chemotherapy dose density (DD) on survival is difficult...
3.
Mavani P, Sok C, Eng N, Marra A, Foroutani L, Alseidi A, et al.
J Am Coll Surg
. 2025 Jan;
PMID: 39831703
Introduction: Pancreatoduodenectomy (PD) may occasionally be indicated for complete removal of periampullary (duodenal and ampullary) adenomas (PAs). As compared with malignant indications, PD for benign or pre-malignant disease is often...
4.
Ghahramani E, Grimm P, Weiss B, Schoenleb N, Knapp A, Wang J, et al.
Phys Med Biol
. 2025 Jan;
70(4).
PMID: 39813814
. Ultrasound echo decorrelation imaging can successfully monitor and control thermal ablation of animal liver and tumor tissueand. However, normal and diseased human liver has substantially different physical properties that...
5.
Narayan R, Fleming A, Gunder M, Zafar S, Abdelsattar Z, Bilir E, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):667-668.
PMID: 39567435
No abstract available.
6.
Narayan R, Fleming A, Gunder M, Zafar S, Abdelsattar Z, Bilir E, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):656-664.
PMID: 39532759
Background: The Annals of Surgical Oncology (ASO) launched a Social Media Committee in 2022 to strategically promote surgical science, boost journal impact, and raise awareness of cutting-edge research. This study...
7.
8.
Jain A, Schultz K, Brainerd M, Murimwa G, Fleming A, Fackche N, et al.
Ann Surg Oncol
. 2024 Sep;
31(13):9112.
PMID: 39313730
No abstract available.
9.
Johnson R, McClelland P, Ahmad S
Surg Clin North Am
. 2024 Sep;
104(5):987-1005.
PMID: 39237173
While pancreatic adenocarcinoma requires surgical resection definitive cure, treatment paradigms are shifting toward a neoadjuvant approach to systemic therapy. Rationale is twofold: micro-metastatic disease is likely present in a majority...
10.
McGough D, Price A, Whitrock J, Hariri H, Patel S, Ahmad S, et al.
J Surg Res
. 2024 Aug;
302:611-620.
PMID: 39182442
Introduction: Surgery followed by pathology-guided adjuvant therapy is standard treatment for colon cancer. Data from the FOxTROT clinical trial showed potential benefit of a 6-wk neoadjuvant chemotherapy (NACT) in T3/T4...